ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HEIDI CHANG MD

Internal Medicine

10,532

$413K

809
751 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $56

MARK PTASKIEWICZ MD

Internal Medicine

10,441

$469K

613
553 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

LESLIE EBER MD

Internal Medicine

10,399

$496K

234
208 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

ALICIA APPEL MD

Internal Medicine

10,399

$419K

404
262 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

FRANK BECKY MD

Internal Medicine

10,348

$393K

736
671 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $56

JAMES GEYMAN MD

Internal Medicine

10,238

$395K

603
535 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $56

COLIN COMBS

Internal Medicine

10,230

$431K

665
613 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

JOHAN LANE MD

Internal Medicine

10,216

$430K

752
679 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

TIMOTHY HOLCOMB

Internal Medicine

10,185

$381K

686
591 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

JOHN FEDACK M.D.

Internal Medicine

9,892

$479K

667
593 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

SUE WILLIAMS M.D.

Internal Medicine

9,816

$455K

644
584 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $56

EDWARD HO MD

Internal Medicine

9,806

$578K

445
393 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $56

DAVID LEON M.D.

Internal Medicine

9,739

$473K

401
339 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $56

JAMES HARDEE MD

Internal Medicine

9,729

$361K

623
576 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

KEITH THOMPSON MD

Internal Medicine

9,718

$441K

490
428 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

HUGH COMER MD

Internal Medicine

9,680

$461K

460
418 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

STEVEN BRODIE MD

Internal Medicine

9,660

$423K

486
436 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $56

RICARDO PADILLA M.D.

Internal Medicine

9,626

$305K

491
322 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$32
Average prescription price

Avg: $56

HAI BUI MD

Internal Medicine

9,578

$898K

552
389 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $56

LUIS CRUZ-CINTRON MD

Internal Medicine

9,530

$322K

509
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $56

MARK MATTHEWS MD

Internal Medicine

9,495

$419K

643
557 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $56

MICHAEL MILLER M.D.

Internal Medicine

9,413

$380K

576
543 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

ROBERT CASH MD

Internal Medicine

9,385

$470K

620
489 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $56

CHRISTOPHER BUCHANAN MD

Internal Medicine

9,373

$569K

285
254 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

RICHARD LAMB M.D.

Internal Medicine

9,362

$418K

381
349 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank